No Data
No Data
Haemonetics: To Use Proceeds for General Corporate Purposes and Growth Initiatives>HAE
Haemonetics: Transaction Expected to Close in First Quarter of 2025 >HAE
Express News | Haemonetics Corp - Deal Valued at up to $67.1 Million
Express News | Haemonetics Announces Sale of Whole Blood Assets to Gvs, S.p.a
Press Release: Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A
ABT Stock Benefits From First Patient Procedures With TAVI System